Themes US R&D Champions ETF
USRD
2 hedge funds and large institutions have $36.8K invested in Themes US R&D Champions ETF in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, reducing their positions, and closing their positions.
81% more capital invested
Capital invested by funds: $20.3K → $36.8K (+$16.5K)
2.74% more ownership
Funds ownership: 1.71% → 4.44% (+2.7%)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GWM
Geneos Wealth Management
Englewood,
Colorado
|
+$19.4K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
GWM
1
Geneos Wealth Management
Englewood,
Colorado
| $35.9K | +$19.4K | +650 | +100% |
|
2
UBS Group
Zurich,
Switzerland
| $911 | – | – | – |
|
USRD Hedge Fund Activity: Q1 2025 in Review
2 of the 7,458 institutional investors tracked by Wall St. Rank reported a position in Themes US R&D Champions ETF (USRD) for Q1 2025, worth a combined $36.8K — up 81% from $20.3K a quarter earlier.
Fund positioning in USRD was balanced in Q1 2025: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Geneos Wealth Management, adding an estimated $19.4K.
- 2 institutional investors held Themes US R&D Champions ETF (USRD) as of Q1 2025, unchanged from Q4 2024.
- Funds reported $36.8K of Themes US R&D Champions ETF stock for Q1 2025, up 81% quarter-over-quarter.
- 0 funds opened new Themes US R&D Champions ETF positions in Q1 2025 and 0 closed out.
- The largest Themes US R&D Champions ETF buyer in Q1 2025 was Geneos Wealth Management, an estimated $19.4K added.
Based on aggregated 13F filings for Q1 2025.